Home › Funds › Trivant Custom Portfolio Group, LLC › ABT

Trivant Custom Portfolio Group, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Trivant Custom Portfolio Group, LLC reported holding 14,608 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$1.4M, representing 0.75% of its reported portfolio and ranking #41 among its reported holdings. Trivant Custom Portfolio Group, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)14.61K sh
Reported value held$1.44M
Portfolio Weight0.75%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Trivant Custom Portfolio Group, LLC's ABT position evolved

Trivant Custom Portfolio Group, LLC first disclosed a stake in ABT in Q3 2023 at 25,155 shares (US$2.4M). The position peaked in Q1 2024 at 24,458 shares, worth US$2.8M. Across 13 filings, Trivant Custom Portfolio Group, LLC increased the stake 1 time(s), trimmed it 5 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 14,608 shares valued at US$1.4M. Notable position changes include a 39% trim in Q3 2024 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 25.16K $2.44M New
Q4 2023 25.14K $2.77M Hold
Q1 2024 24.46K $2.78M Reduce
Q2 2024 24.14K $2.51M Reduce
Q3 2024 14.77K $1.68M Reduce
Q4 2024 14.76K $1.67M Hold
Q1 2025 14.71K $1.95M Hold
Q2 2025 14.62K $1.99M Reduce
Q3 2025 14.80K $1.98M Add
Q4 2025 14.73K $1.85M Hold
Q1 2026 14.79K $1.52M Hold
Q2 2026 14.61K $1.33M Reduce
Q3 2026 14.61K $1.44M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Trivant Custom Portfolio Group, LLC held ABT?

Trivant Custom Portfolio Group, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Trivant Custom Portfolio Group, LLC's current position in ABT?

As of Q3 2026, Trivant Custom Portfolio Group, LLC holds 14.61K shares of ABT (ABBOTT LABORATORIES), valued at $1.44M, representing 0.75% of its reported portfolio and ranking #41.

Has Trivant Custom Portfolio Group, LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), Trivant Custom Portfolio Group, LLC held unchanged its position in ABT. The position peaked in Q1 2024 at 24.46K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.